LeadIQ logo
Learn more at LeadIQ.com

Insights

Expanding Clinical Pipeline Agenus is actively advancing its immuno-oncology portfolio with promising Phase 3 trials and published clinical results, indicating substantial growth potential and opportunities for partners in cancer treatment development.

Strategic Partnerships The company's collaboration with government-funded programs like France's AAC and focus on early-access initiatives present opportunities for organizations to engage in early market entry and combined clinical efforts.

Innovative Immunotherapies Agenus's utilization of antibody therapeutics, adoptive cell therapies, and adjuvants highlights its sophisticated treatment approaches, enabling sales of specialized biotech components and complementary service offerings.

Market Position & Growth With revenue estimates between 100 million and 250 million dollars and a recent increase in short interest, Agenus is poised for strategic expansion, attracting potential partnerships with industry players seeking innovative oncology solutions.

Focus on Refractory Cancers Agenus's focus on highly refractory ovarian and gastrointestinal cancers opens sales avenues for diagnostics, clinical support, and combination therapy partnerships aimed at underserved patient populations.

Agenus Tech Stack

Agenus uses 8 technology products and services including WordPress, Font Awesome, Culture Amp, and more. Explore Agenus's tech stack below.

  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • Culture Amp
    Human Resource Management System
  • jQuery UI
    Javascript Libraries
  • Agiloft
    Project Management
  • HSTS
    Security
  • Akamai Web Application Protector
    Security
  • Adobe Tag Manager
    Tag Management

Media & News

Agenus's Email Address Formats

Agenus uses at least 1 format(s):
Agenus Email FormatsExamplePercentage
First.Last@agenusbio.comJohn.Doe@agenusbio.com
90%
FLast@agenusbio.comJDoe@agenusbio.com
9%
First.Middle@agenusbio.comJohn.Michael@agenusbio.com
1%

Frequently Asked Questions

What is Agenus's phone number?

Minus sign iconPlus sign icon You can contact Agenus's main corporate office by phone at
+1-781-674-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Agenus's stock symbol?

Minus sign iconPlus sign iconAgenus is a publicly traded company; the company's stock symbol is AGEN.

What is Agenus's official website and social media links?

Minus sign iconPlus sign iconAgenus's official website is agenusbio.com and has social profiles on LinkedInCrunchbase.

How much revenue does Agenus generate?

Minus sign iconPlus sign icon As of December 2025, Agenus's annual revenue is estimated to be $25M.

What is Agenus's SIC code NAICS code?

Minus sign iconPlus sign iconAgenus's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Agenus have currently?

Minus sign iconPlus sign iconAs of December 2025, Agenus has approximately 217 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. D.Chief Communications & Government Relations Officer: S. P. N.Chief People Officer (chro): T. C.. Explore Agenus's employee directory with LeadIQ.

What industry does Agenus belong to?

Minus sign iconPlus sign iconAgenus operates in the Biotechnology Research industry.

What technology does Agenus use?

Minus sign iconPlus sign iconAgenus's tech stack includes WordPressFont AwesomeCulture AmpjQuery UIAgiloftHSTSAkamai Web Application ProtectorAdobe Tag Manager.

What is Agenus's email format?

Minus sign iconPlus sign iconAgenus's email format typically follows the pattern of First.Last@agenusbio.com. Find more Agenus email formats with LeadIQ.

How much funding has Agenus raised to date?

Minus sign iconPlus sign icon As of December 2025, Agenus has raised $16M in funding. The last funding round occurred on Jun 03, 2025 for $16M.

When was Agenus founded?

Minus sign iconPlus sign iconAgenus was founded in 1994.

Agenus

Biotechnology ResearchMassachusetts, United States201-500 Employees

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. 

For more information, visit www.agenusbio.com or follow us at @agenus_bio. 

Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/

Section iconCompany Overview

Phone number
+1-781-674-****
Website
agenusbio.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
AGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $16M

    Agenus has raised a total of $16M of funding over 10 rounds. Their latest funding round was raised on Jun 03, 2025 in the amount of $16M.

  • $100M$250M

    Agenus's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $16M

    Agenus has raised a total of $16M of funding over 10 rounds. Their latest funding round was raised on Jun 03, 2025 in the amount of $16M.

  • $100M$250M

    Agenus's revenue is estimated to be in the range of $100M$250M

Company Leadership

  • Stylized image of a person
    R. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. P. N.
    Chief Communications & Government Relations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. C.
    Chief People Officer (chro)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. W.
    Chief Information Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Chief Commercial Transactions Officer
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    B. S.
    Chief Commercial Transactions Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. H.
    Chief Strategy Officer And Head Of Finance
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. D.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    Z. A.
    Head Of Investor Relations & Corporate Development
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.